Project Summary
The MaNaCa project aims to develop the scientific and technological capacity as well as raise the research profile of the Institute for Physical Research of the National Academy of Sciences (IPR-NAS) in Armenia. From a scientific standpoint, MaNaCa will focus on the structural and magnetic characterization of magnetic nanohybrids and their application for cancer therapy. The project's aim will be accomplished by networking IPR-NAS with two internationally-leading research organisations: the Aristotle University of Thessaloniki (AUTH) in Greece and the University of Duisburg – Essen (UDE) in Germany. Throughout the project, the research partners will be supported with the management and dissemination activities by Intelligentsia Consultants Sàrl (INT), a consultancy company based in Luxembourg, which has already collaborated on several occasions with IPR-NAS during the FP7 and H2020 programmes.
From 2019-2022, the partners will carry out a research and innovation strategy with the following objectives:
1. Stimulate scientific excellence and innovation capacity of IPR-NAS with regard to magnetic nanohybrids for cancer therapy.
2. Improve the career prospects of early stage researchers of IPR-NAS and the Twinning partners
3. Raise the research profile of IPR-NAS and the Twinning Partners
These objectives will be centred around a research and innovation strategy focused on two sub-topics:
A. Structural and magnetic characterization of nanohybrids
B. Magnetic particle hyperthermia
In order to accomplish this, the consortium partners will implement a comprehensive set of actions:
- Exchange of senior researchers;
- Exchange of early stage researchers; and
- Dissemination and outreach.
In addition to staff exchanges, the project activities will also include technical training, joint publications, joint participation to conferences, organization of summer schools, workshops and an international conference.
From 2019-2022, the partners will carry out a research and innovation strategy with the following objectives:
1. Stimulate scientific excellence and innovation capacity of IPR-NAS with regard to magnetic nanohybrids for cancer therapy.
2. Improve the career prospects of early stage researchers of IPR-NAS and the Twinning partners
3. Raise the research profile of IPR-NAS and the Twinning Partners
These objectives will be centred around a research and innovation strategy focused on two sub-topics:
A. Structural and magnetic characterization of nanohybrids
B. Magnetic particle hyperthermia
In order to accomplish this, the consortium partners will implement a comprehensive set of actions:
- Exchange of senior researchers;
- Exchange of early stage researchers; and
- Dissemination and outreach.
In addition to staff exchanges, the project activities will also include technical training, joint publications, joint participation to conferences, organization of summer schools, workshops and an international conference.
